Posted in | News | Biofuels | Renewable Energy

Frost & Sullivan Report Suggests Renewable Energy Targets to Sustain European Biopower Market

Europe's aim to produce 20 percent of its total power from renewable sources by 2020 will sustain the region's biomass and biogas power market. Although biomass and biogas installed capacity will widen as a new wave of coal-to-biomass power plant conversions gains momentum, year-on-year revenue growth is likely to decrease.

New analysis from Frost & Sullivan (http://www.energy.frost.com), Opportunities in the Biomass and Biogas Power Market in Europe, finds that the market earned revenues of euro 3.33 billion in 2012 and estimates this to reach euro 3.77 billion in 2017.

"Biopower plants are increasingly preferred as a source for large-scale power generation owing to their low capital requirements," said Frost & Sullivan Energy and Environmental Research Analyst Ashay Abbhi. "Their efficiency, longer operational times, and reliability further boost their popularity over other sources of renewable power generation."

While advances in biomass and biogas power generation will be vital to Europe achieving its ambitious 2020 target, deteriorating economic conditions in the continent have limited market expansion. Countries have cut down or even stopped subsidies for power generation from biomass and biogas, jeopardising the prospects of plant owners.

The lack of steady raw material supply in the region poses another challenge. High-demand customers are willing to pay more to keep their power plants running, which triggers a rise in feedstock and equipment prices, affecting profitability. The withdrawal of government incentive schemes further dampens revenues.

"Government support is necessary for technology development, especially as constant innovation will enable a reduction in capital expenditure," observed Abbhi. "For now, the conversion of coal power plants to biomass plants will be the strongest market trend as it requires far less investment than setting up a greenfield biopower plant."

Going forward, the Western European biopower market, which is dominated by countries such as Germany and the United Kingdom, will slowly give way to opportunities in the developing Central and Eastern Europe markets. Poland is expected to be a hotspot in this region.

If you are interested in more information on this research, please send an e-mail to Chiara Carella, Corporate Communications, at [email protected], with your full contact details.

Opportunities in the Biomass and Biogas Power Market in Europe is part of the Energy & Power Growth Partnership Service program. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

Source: http://www.frost.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Frost & Sullivan. (2019, March 01). Frost & Sullivan Report Suggests Renewable Energy Targets to Sustain European Biopower Market. AZoCleantech. Retrieved on April 26, 2024 from https://www.azocleantech.com/news.aspx?newsID=18607.

  • MLA

    Frost & Sullivan. "Frost & Sullivan Report Suggests Renewable Energy Targets to Sustain European Biopower Market". AZoCleantech. 26 April 2024. <https://www.azocleantech.com/news.aspx?newsID=18607>.

  • Chicago

    Frost & Sullivan. "Frost & Sullivan Report Suggests Renewable Energy Targets to Sustain European Biopower Market". AZoCleantech. https://www.azocleantech.com/news.aspx?newsID=18607. (accessed April 26, 2024).

  • Harvard

    Frost & Sullivan. 2019. Frost & Sullivan Report Suggests Renewable Energy Targets to Sustain European Biopower Market. AZoCleantech, viewed 26 April 2024, https://www.azocleantech.com/news.aspx?newsID=18607.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.